General Information of the Compound
Compound ID
CP0195791
Compound Name
4-N-(3-bromophenyl)-7-chloroquinazoline-4,6-diamine
    Show/Hide
Structure
Formula
C14H10BrClN4
Molecular Weight
349.619
Canonical SMILES
Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1Cl
    Show/Hide
InChI
InChI=1S/C14H10BrClN4/c15-8-2-1-3-9(4-8)20-14-10-5-12(17)11(16)6-13(10)18-7-19-14/h1-7H,17H2,(H,18,19,20)
    Show/Hide
InChIKey
DXPXPVHLPOANFF-UHFFFAOYSA-N
Physicochemical Property
logP
4.3715
Rotatable Bonds
2
Heavy Atom Count
20
Polar Areas
63.83
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5328213
SID: 15648143
ChEMBL ID
CHEMBL63469
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 6.5 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 6.607 nM